In a milestone transaction within the European healthcare technology sector, software private equity firm Thoma Bravo announced and finalised its strategic growth investment in padoa, acquiring a majority stake in the European leader in occupational health, safety, and prevention software. The transaction, executed through the €1.8 billion Thoma Bravo Europe Fund, represents a notable expansion of the firm’s dedicated buyout strategy across core European software markets.

The nexus between individual health and economic productivity has become a focal point of public policy in the United Kingdom, particularly in the wake of post-pandemic shifts in workforce participation. A significant driver of economic inactivity is the prevalence of long-term sickness, with musculoskeletal (MSK) conditions representing a dominant category of morbidity. The traditional bifurcation of health services, delivered by the National Health Service (NHS) and employm